US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist

26.800
-0.280-1.03%

Close Jan 8 16:00 ET

26.800
0.0000.00%

Post 20:01 ET

2.22BMarket Cap-16.96P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beam Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 13.461M	--
--	2024/Q4	-- / 15.654M	--
Nov 5, 2024	2024/Q3	14.269M / 14.132M	--
--	2024/Q2	11.772M / 13.047M	--
--	2024/Q1	7.410M / 14.664M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 13.461M--

--2024/Q4-- / 15.654M--

Nov 5, 20242024/Q314.269M / 14.132M--

--2024/Q211.772M / 13.047M--

--2024/Q17.410M / 14.664M--

Unlock Free Earnings Estimates

Open Account

Beam Therapeutics Earnings Reports

Beam Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5, 2024 09:11 ET

Beam Therapeutics | 8-K: Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs

Nov 5, 2024 07:06 ET

Beam Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6, 2024 08:58 ET

Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results

Aug 6, 2024 07:13 ET

Trending US Stocks

Symbol Mini Chart % Chg

Collegium Pharmaceutical

Halozyme Therapeutics

Unlock the Full List

Analysis

Analyst Rating

Updated: Jan 9, 2025

Buy

Buy
73.33%
Hold
26.67%
Sell
0.00%

Price Target

No Data